<a href="https://2011.igem.org/Team:DTU-Denmark-2/Project/Achievements#Fullfillment of medal requirements" class="h1"> Fullfillment of medal requirements</a><br><br>
+
<a href="https://2011.igem.org/Team:DTU-Denmark-2/Project/Achievements#Fulfilment of medal requirements" class="h1"> Fulfilment of medal requirements</a><br><br>
Line 82:
Line 82:
<p align="justify">
<p align="justify">
<br>
<br>
-
The team came together during a course in mammalian cell biology in June, and that was when the idea of iGEM popped into our heads. Eventhough we started the iGEM project late June, we have managed to design a fully standardized cloning system called Plug'n Play with DNA. We thought that time should be spent on making cool iGEM projects, instead of struggeling with unwanted restriction sites and cumbersome assembly systems. This led us to standardize USER fusion by designing the<a hret="https://2011.igem.org/Team:DTU-Denmark-2/Project/overview"> Plug'Play with DNA </a>assembly system.</p><br>
+
The team came together during a course in mammalian cell biology in June, and that was when the idea of iGEM popped into our heads. Even though we started the iGEM project late June, we have managed to design a fully standardized cloning system called Plug'n Play with DNA. We thought that time should be spent on making cool iGEM projects, instead of struggling with unwanted restriction sites and cumbersome assembly systems. This led us to standardize USER fusion by designing the<a hret="https://2011.igem.org/Team:DTU-Denmark-2/Project/overview"> Plug'Play with DNA </a>assembly system.</p><br>
<font face="arial" size="3">
<font face="arial" size="3">
Line 102:
Line 102:
We have characterized the two fungal promoters, P<i>alcA</i> and DMKP-P6, and demonstrated function of the cytomegalovirus (CMV) promoter in mammalian cells.
We have characterized the two fungal promoters, P<i>alcA</i> and DMKP-P6, and demonstrated function of the cytomegalovirus (CMV) promoter in mammalian cells.
The <a href="https://2011.igem.org/Team:DTU-Denmark-2/results/Characterisation">characterization</a> of the fungal promoters was successfully performed with an X-gal analysis, where the expression of ß-galactosidase results in blue colonies. Furthermore, quantitative ß-galactosidase and Bradford assays were performed in order to measure protein production and ß-galactosidase activity. Both promoters proved to be of medium strength.
The <a href="https://2011.igem.org/Team:DTU-Denmark-2/results/Characterisation">characterization</a> of the fungal promoters was successfully performed with an X-gal analysis, where the expression of ß-galactosidase results in blue colonies. Furthermore, quantitative ß-galactosidase and Bradford assays were performed in order to measure protein production and ß-galactosidase activity. Both promoters proved to be of medium strength.
-
For demonstration of the Plug' Play with DNA system in <a href="https://2011.igem.org/Team:DTU-Denmark-2/results/Proofofconcept/mammalian">mammalian cell</a> lines, U-2 OS was transfected with plasmids containing genes encoding fluorescent proteins. The transfected cells capability to express the fluorescent proteins was investigated with confocal microscopy, which resulted in amazing <a href="https://2011.igem.org/Team:DTU-Denmark-2/results/Proofofconcept/mammalian">pictures</a> of fluorescent peroxisomes and colored U-2 SO cells.
+
For demonstration of the Plug' Play with DNA system in <a href="https://2011.igem.org/Team:DTU-Denmark-2/results/Proofofconcept/mammalian">mammalian cell</a> lines, U-2 OS was transfected with plasmids containing genes encoding fluorescent proteins. The transfected cells capability to express the fluorescent proteins was investigated with confocal microscopy, which resulted in amazing <a href="https://2011.igem.org/Team:DTU-Denmark-2/results/Proofofconcept/mammalian">pictures</a> of fluorescent peroxisomes and coloured U-2 SO cells.
-
Some of the submitted BioBricks have been successfully sequenced, and the data has been examinated in order to verify that no mutations or incorrect insertions had occurred. The analysis of the sequencing data showed that all the sequenced Plug 'n' Play BioBricks had been correctly assembled without mutations. The sequencing and the characterization both showed that the system works as expected in <i>A. nidulans</i> and in the mammalian cell line U-2 OS.
+
Some of the submitted BioBricks have been successfully sequenced, and the data has been examined in order to verify that no mutations or incorrect insertions had occurred. The analysis of the sequencing data showed that all the sequenced Plug 'n' Play BioBricks had been correctly assembled without mutations. The sequencing and the characterization both showed that the system works as expected in <i>A. nidulans</i> and in the mammalian cell line U-2 OS.
</p>
</p>
<br><br>
<br><br>
-
<a name="Fullfillment of medal requirements"></a><h1><b>Fullfillment of medal requirements</b></h1>
+
<a name="Fulfilment of medal requirements"></a><h1><b>Fulfilment of medal requirements</b></h1>
We have made a description of our project (see The project), and submitted parts can be found under Results.<br><br>
We have made a description of our project (see The project), and submitted parts can be found under Results.<br><br>
-
<input type="checkbox" disabled="true"><b> Present a poster and a talk at the iGEM Jamboree</b><br>
+
<input type="checkbox" checked disabled="true"><b> Present a poster and a talk at the iGEM Jamboree</b><br>
We plan to make an excellent presentation and a magnificent poster that will be transported on first class from Denmark to Amsterdam right before the Jamboree. <br><br>
We plan to make an excellent presentation and a magnificent poster that will be transported on first class from Denmark to Amsterdam right before the Jamboree. <br><br>
<input type="checkbox" checked disabled="true"> <b>At least one new submitted and well-characterized standard BioBrick Part or Device. A new application of and outstanding documentation (quantitative data showing the Part’s/ Device’s function) of a previously existing BioBrick part in the “Experience” section of that BioBrick’s Registry entry also counts.</b><br>
<input type="checkbox" checked disabled="true"> <b>At least one new submitted and well-characterized standard BioBrick Part or Device. A new application of and outstanding documentation (quantitative data showing the Part’s/ Device’s function) of a previously existing BioBrick part in the “Experience” section of that BioBrick’s Registry entry also counts.</b><br>
We have submitted 49 new <a hret="https://2011.igem.org/Team:DTU-Denmark-2/results/submitted_biobricks">BioBricks</a>.
We have submitted 49 new <a hret="https://2011.igem.org/Team:DTU-Denmark-2/results/submitted_biobricks">BioBricks</a>.
<br><br>
<br><br>
-
Silver
+
-
<br><br>
+
<div class="text">
+
<font color=" #939393" face="arial" size="5">
+
+
<b>Silver</b><br>
+
</font>
+
<input type="checkbox" checked disabled="true"><b>Demonstrate that at least one new BioBrick Part or Device of your own design and construction works as expected</b><br>
<input type="checkbox" checked disabled="true"><b>Demonstrate that at least one new BioBrick Part or Device of your own design and construction works as expected</b><br>
We have demonstrated the function of the device, <a hret=!http://partsregistry.org/Part:BBa_K678002"> BBa_K678002</a>, that has been transfected into the mammalian cell line, U-2 OS. Furthermore, characterization of fungal promoter parts have been executed. These results can be viewed at our homepage or in the BioBrick registry for <a href="http://partsregistry.org/Part:BBa_K678000">BBa_K678000</a> and <a href="http://partsregistry.org/Part:BBa_K678001">BBa_K678001</a><br><br>
We have demonstrated the function of the device, <a hret=!http://partsregistry.org/Part:BBa_K678002"> BBa_K678002</a>, that has been transfected into the mammalian cell line, U-2 OS. Furthermore, characterization of fungal promoter parts have been executed. These results can be viewed at our homepage or in the BioBrick registry for <a href="http://partsregistry.org/Part:BBa_K678000">BBa_K678000</a> and <a href="http://partsregistry.org/Part:BBa_K678001">BBa_K678001</a><br><br>
<input type="checkbox" checked disabled="true"><b>Characterize the operation of at least one new BioBrick Part or Device and enter this information in the “Main Page” section of that Part’s/Device’s Registry entry.</b><br>
<input type="checkbox" checked disabled="true"><b>Characterize the operation of at least one new BioBrick Part or Device and enter this information in the “Main Page” section of that Part’s/Device’s Registry entry.</b><br>
-
<br>
<br>
<br>
-
Gold
+
-
<br>
+
<div class="text">
+
<font color=" #EFC100" face="arial" size="5">
+
<br><br>
+
<b>Gold</b>
+
</font>
<br>
<br>
-
<input type="checkbox" disabled="true"><b>Improve the function of an existing BioBrick Part or Device (created by another team or your own institution in a previous year) and enter this information in the Registry (in the “Experience” section of that BioBrick’s Registry entry), and don't forget to create a new registry page for the improved part.</b><br><br>
+
<input type="checkbox" checked disabled="true"><b>Improve the function of an existing BioBrick Part or Device (created by another team or your own institution in a previous year) and enter this information in the Registry (in the “Experience” section of that BioBrick’s Registry entry), and don't forget to create a new registry page for the improved part.</b><br><br>
The team came together during a course in mammalian cell biology in June, and that was when the idea of iGEM popped into our heads. Even though we started the iGEM project late June, we have managed to design a fully standardized cloning system called Plug'n Play with DNA. We thought that time should be spent on making cool iGEM projects, instead of struggling with unwanted restriction sites and cumbersome assembly systems. This led us to standardize USER fusion by designing the Plug'Play with DNA assembly system.
Our Plug 'n' Play with DNA kit consist of:
49 ready-to-use BioBricks.
21 backup plasmids.
A quick 'n' easy guide on how to customize the standard
To ensure that the BioBricks and devices have been assembled correctly we have tested the functionality of them in Aspergillus nidulans and in mammalian cells.
We have characterized the two fungal promoters, PalcA and DMKP-P6, and demonstrated function of the cytomegalovirus (CMV) promoter in mammalian cells.
The characterization of the fungal promoters was successfully performed with an X-gal analysis, where the expression of ß-galactosidase results in blue colonies. Furthermore, quantitative ß-galactosidase and Bradford assays were performed in order to measure protein production and ß-galactosidase activity. Both promoters proved to be of medium strength.
For demonstration of the Plug' Play with DNA system in mammalian cell lines, U-2 OS was transfected with plasmids containing genes encoding fluorescent proteins. The transfected cells capability to express the fluorescent proteins was investigated with confocal microscopy, which resulted in amazing pictures of fluorescent peroxisomes and coloured U-2 SO cells.
Some of the submitted BioBricks have been successfully sequenced, and the data has been examined in order to verify that no mutations or incorrect insertions had occurred. The analysis of the sequencing data showed that all the sequenced Plug 'n' Play BioBricks had been correctly assembled without mutations. The sequencing and the characterization both showed that the system works as expected in A. nidulans and in the mammalian cell line U-2 OS.
Fulfilment of medal requirements
Bronze Team registration
Complete Judging form
Team Wiki
We have made a description of our project (see The project), and submitted parts can be found under Results.
Present a poster and a talk at the iGEM Jamboree
We plan to make an excellent presentation and a magnificent poster that will be transported on first class from Denmark to Amsterdam right before the Jamboree.
At least one new submitted and well-characterized standard BioBrick Part or Device. A new application of and outstanding documentation (quantitative data showing the Part’s/ Device’s function) of a previously existing BioBrick part in the “Experience” section of that BioBrick’s Registry entry also counts.
We have submitted 49 new BioBricks.
Silver Demonstrate that at least one new BioBrick Part or Device of your own design and construction works as expected
We have demonstrated the function of the device, BBa_K678002, that has been transfected into the mammalian cell line, U-2 OS. Furthermore, characterization of fungal promoter parts have been executed. These results can be viewed at our homepage or in the BioBrick registry for BBa_K678000 and BBa_K678001
Characterize the operation of at least one new BioBrick Part or Device and enter this information in the “Main Page” section of that Part’s/Device’s Registry entry.
Gold Improve the function of an existing BioBrick Part or Device (created by another team or your own institution in a previous year) and enter this information in the Registry (in the “Experience” section of that BioBrick’s Registry entry), and don't forget to create a new registry page for the improved part.
Help another iGEM team by, for example, characterizing a part, debugging a construct, or modeling or simulating their system. We have helped the iGEM team Copenhagen with the design and assembly of some of their BioBricks.
Outline and detail a new approach to an issue of Human Practice in synthetic biology as it relates to your project, such as safety, security, ethics, or ownership, sharing, and innovation.
"
